Gilead Sciences Inc (GILD)
90.20
+0.36
(+0.40%)
USD |
NASDAQ |
Nov 05, 16:00
90.39
+0.19
(+0.21%)
After-Hours: 20:00
Gilead Sciences Market Cap: 112.30B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 111.85B |
| November 01, 2024 | 111.44B |
| October 31, 2024 | 110.58B |
| October 30, 2024 | 109.92B |
| October 29, 2024 | 109.66B |
| October 28, 2024 | 110.51B |
| October 25, 2024 | 110.80B |
| October 24, 2024 | 110.53B |
| October 23, 2024 | 108.60B |
| October 22, 2024 | 109.76B |
| October 21, 2024 | 107.43B |
| October 18, 2024 | 107.97B |
| October 17, 2024 | 108.76B |
| October 16, 2024 | 108.00B |
| October 15, 2024 | 106.85B |
| October 14, 2024 | 105.89B |
| October 11, 2024 | 105.76B |
| October 10, 2024 | 105.41B |
| October 09, 2024 | 107.24B |
| October 08, 2024 | 106.09B |
| October 07, 2024 | 105.11B |
| October 04, 2024 | 105.31B |
| October 03, 2024 | 104.79B |
| October 02, 2024 | 105.50B |
| October 01, 2024 | 104.50B |
| Date | Value |
|---|---|
| September 30, 2024 | 104.38B |
| September 27, 2024 | 104.09B |
| September 26, 2024 | 103.38B |
| September 25, 2024 | 102.35B |
| September 24, 2024 | 104.32B |
| September 23, 2024 | 104.57B |
| September 20, 2024 | 104.50B |
| September 19, 2024 | 104.45B |
| September 18, 2024 | 104.44B |
| September 17, 2024 | 103.40B |
| September 16, 2024 | 103.53B |
| September 13, 2024 | 103.10B |
| September 12, 2024 | 103.53B |
| September 11, 2024 | 100.77B |
| September 10, 2024 | 101.39B |
| September 09, 2024 | 98.57B |
| September 06, 2024 | 98.01B |
| September 05, 2024 | 98.07B |
| September 04, 2024 | 98.52B |
| September 03, 2024 | 99.23B |
| August 30, 2024 | 98.35B |
| August 29, 2024 | 98.91B |
| August 28, 2024 | 97.81B |
| August 27, 2024 | 95.86B |
| August 26, 2024 | 95.81B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
71.01B
Minimum
Dec 30 2020
112.30B
Maximum
Nov 05 2024
89.21B
Average
87.35B
Median
Market Cap Benchmarks
| Merck & Co Inc | 257.66B |
| Eli Lilly and Co | 765.50B |
| Amgen Inc | 171.60B |
| Pfizer Inc | 158.55B |
| Bristol-Myers Squibb Co | 113.46B |
Market Cap Related Metrics
| PE Ratio | 110.00 |
| PS Ratio | 4.063 |
| Price to Book Value | 6.143 |
| Price to Free Cash Flow | 16.38 |
| Price | 90.20 |
| Earnings Yield | 0.91% |
| Operating PE Ratio | 15.67 |
| Normalized PE Ratio | 21.16 |